[go: up one dir, main page]

DK1855705T3 - Antibiotikum 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse deraf - Google Patents

Antibiotikum 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse deraf

Info

Publication number
DK1855705T3
DK1855705T3 DK05723117.7T DK05723117T DK1855705T3 DK 1855705 T3 DK1855705 T3 DK 1855705T3 DK 05723117 T DK05723117 T DK 05723117T DK 1855705 T3 DK1855705 T3 DK 1855705T3
Authority
DK
Denmark
Prior art keywords
antibiotic
factors
compositions
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
DK05723117.7T
Other languages
English (en)
Inventor
Ameriga Lazzarini
Luciano Gastaldo
Gianpaolo Candiani
Ismaela Ciciliato
Daniele Losi
Flavia Marinelli
Enrico Selva
Franco Parenti
Original Assignee
Sentinella Pharmaceuticals Inc Sentinella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/035,296 external-priority patent/US7319088B2/en
Application filed by Sentinella Pharmaceuticals Inc Sentinella filed Critical Sentinella Pharmaceuticals Inc Sentinella
Priority claimed from PCT/US2005/004843 external-priority patent/WO2006075988A1/en
Application granted granted Critical
Publication of DK1855705T3 publication Critical patent/DK1855705T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK05723117.7T 2005-01-12 2005-01-19 Antibiotikum 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse deraf DK1855705T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/035,296 US7319088B2 (en) 2003-07-18 2005-01-12 Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
PCT/US2005/004843 WO2006075988A1 (en) 2005-01-12 2005-01-19 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Publications (1)

Publication Number Publication Date
DK1855705T3 true DK1855705T3 (da) 2012-10-15

Family

ID=39705004

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05723117.7T DK1855705T3 (da) 2005-01-12 2005-01-19 Antibiotikum 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse deraf

Country Status (18)

Country Link
EP (1) EP1855705B1 (da)
JP (1) JP4189026B2 (da)
CN (1) CN101098707B (da)
AU (1) AU2005324536B2 (da)
BR (1) BRPI0519325A2 (da)
CA (1) CA2593818C (da)
DK (1) DK1855705T3 (da)
EA (1) EA012164B1 (da)
ES (1) ES2391085T3 (da)
HR (1) HRP20120809T1 (da)
IL (1) IL184376A0 (da)
MX (1) MX2007008512A (da)
NO (1) NO20073491L (da)
NZ (1) NZ556369A (da)
PL (1) PL1855705T3 (da)
RS (1) RS52513B (da)
SI (1) SI1855705T1 (da)
TN (1) TNSN07262A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351687B2 (en) * 2003-07-18 2008-04-01 Vicuron Pharmaceuticals, Inc. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
BRPI0822946A2 (pt) * 2008-11-24 2015-06-23 Sentinella Pharmaceuticals Inc Sentinella Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218362B1 (en) * 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
US6551591B1 (en) * 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
MXPA06000691A (es) * 2003-07-18 2006-04-11 Vicuron Pharm Inc Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas.

Also Published As

Publication number Publication date
MX2007008512A (es) 2007-09-14
AU2005324536B2 (en) 2009-03-05
NZ556369A (en) 2009-08-28
TNSN07262A1 (fr) 2008-12-31
HRP20120809T1 (hr) 2012-11-30
IL184376A0 (en) 2007-10-31
NO20073491L (no) 2007-08-03
EA200701267A1 (ru) 2008-02-28
ES2391085T3 (es) 2012-11-21
AU2005324536A1 (en) 2006-07-20
EP1855705A4 (en) 2008-11-12
JP4189026B2 (ja) 2008-12-03
JP2008526961A (ja) 2008-07-24
RS52513B (en) 2013-04-30
EP1855705A1 (en) 2007-11-21
SI1855705T1 (sl) 2012-11-30
BRPI0519325A2 (pt) 2009-01-13
EA012164B1 (ru) 2009-08-28
PL1855705T3 (pl) 2012-12-31
CN101098707A (zh) 2008-01-02
CA2593818A1 (en) 2006-07-20
CA2593818C (en) 2014-12-16
CN101098707B (zh) 2011-11-30
EP1855705B1 (en) 2012-07-11

Similar Documents

Publication Publication Date Title
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
PT1506781E (pt) Composicao para tratamento vaginal
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
ZA200709763B (en) 2,4-diamino-pyrimidines used as aurora inhibitors
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
IL189781A0 (en) Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
DK1902050T3 (da) Oxazolidinonderivater og anvendelse deraf som antibiotika
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
IL187534A0 (en) Thiazole derivatives, use thereof and pharmaceutical compositions containing them
DK1587478T3 (da) Farmaceutisk sammensætning
DK1858481T3 (da) Ophthalmologiske sammensætninger og anvendelse deraf
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
ZA200705495B (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
TWI340167B (en) Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
BRPI0614413A2 (pt) composto, e, composição farmacêutica
DK1940840T3 (da) 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf
BRPI0614412A2 (pt) composto, e, composição farmacêutica
NO344962B1 (no) Amorf cesiumaluminiumfluorklompleks, dets fremstilling og bruk
IL186745A0 (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
DK1812120T3 (da) Hudbeskyttende, alkalinitetskontrollerende præparat og anvendelsen deraf
DK1855705T3 (da) Antibiotikum 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse deraf
PL1791872T3 (pl) Biotynylowane heksadekasacharydy, kompozycje farmaceutyczne i ich zastosowanie
ZA200710147B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents